Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective
Yoshinori Watanabe,1 Sakiko Yamada,2 Tempei Otsubo,3 Toshiaki Kikuchi4 1Himorogi Psychiatric Institute, Tokyo, Japan; 2Medical Affairs, Otsuka Pharmaceutical Co. Ltd, Tokyo, Japan; 3Department of Psychiatry, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan; 4Department of...
Saved in:
Main Authors: | Watanabe Y (Author), Yamada S (Author), Otsubo T (Author), Kikuchi T (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical role of brexpiprazole in depression and schizophrenia
by: Parikh NB, et al.
Published: (2017) -
Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
by: Bruijnzeel D, et al.
Published: (2016) -
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
by: Aigbogun MS, et al.
Published: (2018) -
Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study
by: Yusuke Arai, et al.
Published: (2023) -
Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication)
by: Jun Ishigooka, et al.
Published: (2020)